Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
Clinical trial NCT03109301 · WITHDRAWN
Trial details
- NCT number
- NCT03109301
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-07
- Primary completion
- 2019-03-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.